Haemophilus ducreyi is the causative agent of chancroid, a sexually transmitted genital ulcer disease. Chancroid is prevalent in certain areas of Africa, Asia, and Latin America (34) ; however, sporadic outbreaks occur in the United States (40) . Chancroid has been linked to the transmission of the human immunodeficiency virus (HIV), especially in areas where both diseases are prevalent (21, 34, 39, 40) .
Strain 35000 and its human-passaged derivative, strain 35000HP, have been investigated extensively. Putative virulence determinants, including a hemolytic cytotoxin (2, 28, 45) , cytolethal distending toxin (6) (7) (8) , the serum resistance-conferring proteins DsrA and DltA (12, 24) , and a hemoglobinbinding protein (11, 36) , have been identified and characterized in this genetic background. The structure of the lipooligosaccharide(s) (LOS) and many of the glycosyltransferases responsible for the synthesis of the LOS have also been identified and characterized (3-5, 13, 15, 16, 25-27, 37, 38) . 35000HP LOS contains three L-glycero-D-manno-heptose (LD-Hep) residues linked to a phosphorylated 3-deoxy-Dmanno-octulosonic acid (Kdo). The first heptose residue is substituted with the pentasaccharide Gal␤1-4GlcNAc␤1-3Gal␤1-4DDHep␣1-6Glu␤1-4 (Fig. 1A) . The nonreducing galactose can be further substituted with sialic acid when it is available (16, 27) . Most of the isolates examined produce this LOS structure (1, 32) .
Recently, a second class of isolates was recognized based on proteomic analysis (31) and the analysis of the genes encoding several surface proteins, including DsrA (44) . One of these isolates, strain 33921, produces a LOS that lacks D-glycero-D-mannoheptose. In this LOS, the first LD-heptose residue is substituted with the trisaccharide GlcNAc␤1-3Gal␤1-4Glc␤1-4 ( Fig. 1B ) (25) . The LOS of strain 33921 does not contain sialic acid, even when sialic acid is present at high concentrations (25) .
Since the LOS from strain 33921 does not contain DD-heptose, we wanted to determine whether strain 33921 had the gene encoding the DD-heptosyltransferase. The galactose I transferase and the DD-heptosyltransferase in strain 35000HP are encoded by the lbgAB genes (alternatively designated losAB genes) (15, 35, 42, 46) , which are flanked by the housekeeping genes rpmE and xthA (Fig. 2) . In the present study, we characterized this region of the 33921 genome. Our findings demonstrate that the gene arrangement in this region of the 33921 genome is identical to that of 35000HP; that is, two glycosyltransferases flanked by the rpmE and xthA genes (Fig.  2) . However, whereas the rpmE and xthA genes are highly conserved, the genes encoding the two glycosyltransferases are not highly homologous to the lbgAB 35000HP genes. We describe our findings here regarding the function of the lbgAB 33921 genes.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. The bacterial strains and plasmids used in the present study are listed in Table 1 . H. ducreyi strains were grown on chocolate agar or in brain heart infusion broth as described previously (28) . Streptomycin was used at 20 g/ml as necessary. Chloramphenicol was used at 1 g/ml on transformation plates or at 0.5 g/ml when clones were isolated. All Escherichia coli strains were grown on Luria-Bertani plates or in Luria-Bertani broth. When necessary, this medium included X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) at 40 g/ml and/or the appropriate antibiotics. Ampicillin was used at 50 g/ml, kanamycin was used at 20 g/ml, and streptomycin was used at 20 g/ml.
Recombinant DNA methodology. Plasmids were isolated by utilizing purification kits (QIAGEN, Chatsworth, CA). Restriction enzymes were purchased from New England Biolabs (Beverly, MA), and T4 DNA ligase was purchased from Invitrogen (Grand Island, NY). Standard recombinant DNA methods were used.
DNA sequence was determined through cycle sequencing using ABI Prism dye terminator cycle sequencing ready reaction kits (Applied Biosystems, Foster City, CA). Excess dye terminators were removed by passage through Centriflex gel filtration cartridges (Edge BioSystems, Gaithersburg, MD), and the sequence was determined on an ABI 377 or an ABI 3130 DNA sequencer. Sequence analysis and comparisons were performed with Lasergene software (DNAStar, Madison, WI).
Determination of the sequence of the rpmE-xthA genomic region in strain 33921. To determine whether strain 33921 had the lbgB gene, which encodes for the DD-heptosyltransferase, we probed HincII-digested 33921 chromosomal DNA with a probe containing portions of the lbgB and xthA genes from 35000HP. A band approximately 2.2 kb in size was detected (data not shown). To isolate the DNA that reacted with the probe, a partial genomic library was generated by digesting 33921 chromosomal DNA with HincII and collecting 2-to 2.4-kb fragments. This HincII digested chromosomal DNA was ligated into the lowcopy vector pWKS30 (43) and transformed into the pcn strain of E. coli. The library was then rescreened by colony blotting. A positive clone was identified from this screen and designated pRSM2207. This clone was sequenced, and a homologue of the xthA gene was identified, as well as a portion of a glycosyltransferase gene. In order to complete the sequence of this region, PvuIIdigested DNA from strain 33921 was screened by Southern analysis using a probe containing the newly identified partial 33921 glycosyltransferase. A band of approximately 8 kb hybridized to the probe (data not shown). PvuII-digested genomic DNA was separated on an agarose gel; 6-to 9-kb fragments were isolated and then cloned into EcoRV-digested pWKS30. These clones were transformed into the E. coli pcn strain. Colony blots were performed on the transformants using the partial 33921 glycosyltransferase probe. A positive clone was identified and designated pRSM2287. Additional sequencing was performed on this clone to complete the sequence of the glycosyltransferase and the adjacent genes. Two glycosyltransferases were identified between the rpmE and xthA genes. Since the location is the same genomic context as the lbgAB genes from strain 35000HP, they were designated lbgA 33921 and lbgB 33921 , respectively. The sequence from this region of the strain 33921 genome has been assigned the GenBank accession number DQ646555.
Cloning of the lbgAB genes. The lbgA 33921 gene was amplified from chromosomal DNA by PCR using primers 1 (5Ј-AATTAAAACACGCTCAACAGTA GA-3Ј) and 2 (5Ј-ATCCCATAAATCAATAAGACTACC-3Ј). Similarly, the lbgB 33921 gene was amplified with primers 3 (5Ј-TGGGGAAATACAACAGG T-3Ј) and 4 (5Ј-AGAAATCAGAGCTATGGAAAAACC-3Ј), and the lbgAB 33921 genes were amplified by using primers 1 and 4. The amplicons were TA cloned into vector pCR2.1 (Invitrogen) and then sequenced to verify that there were no PCR-induced errors. An EcoRI fragment containing the lbgA gene was isolated and cloned into the shuttle vector pLS88 (9) to create plasmid pLBGA (Fig. 2) . Similarly, the EcoRI fragment containing the lbgB gene was cloned into pLS88 ( Fig. 2) . Plasmids containing the insert in both orientations relative to the plasmid backbone were saved as pLBGB and pLBGBR. The lbgAB 33921 gene cluster was cloned as a NotI-to-HindIII fragment into pLSSK, a pLS88 derivative containing the lacZ␣ region of pBluescript SK(Ϫ) (45) that had been digested with the same enzymes to create pLBGAB (Fig. 2) .
Expression of strain 33921 glycosyltransferases in strains 35000HP-RSM2 and 35000HP-RSM223. The pLBGA, pLBGB, and pLBGBR plasmids were transformed into strain 35000HP-RSM2, a previously described derivative of strain 35000HP containing an insertionally inactivated lbgB, the DD-heptosyltransferase gene, as described by Young et al. (46) . The resulting strains were designated 35000HP-RSM2(pLBGA), 35000HP-RSM2(pLBGB), and 35000HP-RSM2(pLBGBR), respectively.
A derivative of strain 35000HP containing mutations in both the lbgB 35000HP gene and the lgtA gene, encoding the N-acetylglucosamine glycosyltransferase, 2 , and extracted by using the hot phenol micromethod (18) . Neuraminidase-treated LOS samples were reconstituted in 5 l of 2ϫ neuraminidase buffer (100 mM sodium acetate, 8 mM calcium chloride [pH 5.5]) and incubated overnight at 37°C with 5 mU of neuraminidase isolated from Vibrio cholerae (5 l of a 1-U/ml solution; Roche, Indianapolis, IN). Samples of the extracted LOS were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 15% gel as previously described (23) and were visualized by silver staining (41) .
Mass spectrometry analysis. Water soluble O-deacylated LOS (O-LOS) samples were prepared by treating the LOS with 50 l of anhydrous hydrazine, followed by acetone precipitation (29) . Lyophilized O-LOS samples were desalted by reconstitution in double-distilled H 2 O (ddH 2 O) and drop dialysis using 0.025-m-pore-size nitrocellulose membranes (Millipore, Bedford, MA). Samples were then lyophilized and reconstituted in 5 to 10 l of ddH 2 O. Before the samples were loaded onto the target, they were mixed 1:1 (vol/vol) with matrix (50 mg of 2,5-dihydroxybenzoic acid [Laser Biolabs, Sophia-Antipolis Cedex, France]/ml in 70% acetonitrile). For the analysis of O-LOS, matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) using a ThermoElectron (San Jose, CA) vMALDI-LTQ linear-ion trap mass spectrometer was performed. The vMALDI source uses an SI N2 laser (337.3 nm) with a 20-Hz firing rate. The instrument was run in negative-ion mode with a laser intensity of 40, and spectra were recorded using the automated gain control to control the number of laser shots and the automatic spectrum filter tool.
␤-Galactosidase treatment of O-LOS. O-LOS from one to two plates of bacteria was treated with ␤(1-4)galactosidase (Prozyme, San Leandro, CA) isolated from Streptococcus pneumoniae. O-LOS was incubated with 10 or 20 mU of enzyme, 10 l of the provided 5ϫ buffer (250 mM sodium phosphate [pH 6)], and the volume was brought to a total of 50 l with ddH 2 O. Incubations were done at 37°C for 20 to 24 h. Samples were boiled for 5 min to stop the reaction. The samples were concentrated by using YM-3 Microcon filters (Millipore) as previously described (22) . Samples were reconstituted in 5 to 10 l of ddH 2 O, and 1 l of each sample was spotted onto the MALDI target plate. Once samples had dried they were overlaid with 0.5 to 1 l of 2,5-dihydroxybenzoic acid matrix (see above). Samples were analyzed by MALDI-MS using an Applied Biosystems (Framingham, MA) Voyager DE time-of-flight mass spectrometer. Mass spectra were determined in linear negative-ion mode with a nitrogen laser (337 nm) under delayed extraction conditions: a 165-ns delay time, with a grid voltage of 94% of full acceleration voltage (20 kV). Mass spectra were acquired, averaged (typically 100 laser shots), and internally calibrated.
RESULTS AND DISCUSSION
Previously, our laboratory noted that the two-dimensional SDS-PAGE profiles of proteins from strains 35000HP and 33921 were significantly different (31) . In order to independently access the relatedness of the two isolates, we sequenced the 16S gene from strain 33921 (GenBank accession no. AY513483) and determined that it is 99% identical to the gene from strain 35000HP (GenBank accession no. NC_002940). In a different study, White et al. observed that a murine monoclonal antibody directed against the DsrA protein from strain 35000HP failed to bind to strains CIP542 ATCC and HMC112 (44) . Sequence analysis of the DsrA proteins from strains CIP542 ATCC and 35000HP determined that they are 48% identical. That study also showed that strains that did not bind the DsrA antibody also seemed to have a truncated LOS structure when visualized on a silver-stained SDS-PAGE (44).
These studies, among others, led to the hypothesis that there were at least two classes of H. ducreyi strains.
The structure of the LOS from the atypical strain 33921 has been reported (25) . This LOS lacks the D-glycero-D-mannoheptose found in the LOS of strain 35000HP. Since lbgB encodes for the DD-heptosyltransferase, we were interested in determining whether the lbgB gene was absent in strain 33921 or whether the lack of DD-heptose in the LOS was the result of phase-variable gene expression. The lbgAB genes in strain 35000HP are localized between the rpmE and xthA genes (Fig.  2) . We therefore determined the sequence of this region of the chromosome of strain 33921. The gene arrangement in this region is the same as that observed in strain 35000HP (15, 35) . That is, two glycosyltransferase genes are present between the rpmE and xthA genes in the chromosome of both strains. The two newly identified glycosyltransferase genes in strain 33921 were designated lbgA 33921 and lbgB 33921 (Fig. 2) . The derived amino acid sequences of the rpmE genes from strains 35000HP and 33921 are 97% identical. Similarly, the derived amino acid sequences of the two xthA genes are also 97% identical. In contrast to the high level of homology observed between the flanking genes, the glycosyltransferases are not highly homologous. The derived amino acid sequence of the strain 33921 glycosyltransferase gene, designated lbgA 33921 , is 37% identical to the derived amino acid sequence of the lbgA 35000HP gene. Similarly, the derived amino acid sequence of the strain 33921 glycosyltransferase gene, designated lbgB 33921 , is 23% identical to the derived amino acid sequence of the lbgB 35000HP gene.
The predicted gene product of the lbgA 33921 gene is most similar to the Lob1 protein of Histophilus somni (19) and the Lex2B protein of Haemophilus influenzae (20) . The Lob1 gene contains a number of tandem repeat nucleotide sequences that are thought to mediate phase variation of the LOS glycoforms in H. somni (19) . Since no tandem repeat nucleotide sequences were observed in the lbgA 33921 gene, there is no indication that this gene is phase variable. The predicted gene product of the lbgB 33921 gene is most similar to a glycosyltransferase group 8 member, Hi0258 (accession no. P43974), from H. influenzae strain KW20 (14) .
Since the two housekeeping genes, xthA and rpmE, are 5Ј and 3Ј of two glycosyltransferase genes in the chromosomes of both strain 35000HP and strain 33921, the lack of DD-heptose in the LOS of 33921 appears to be due to the absence of the lbgB 35000HP gene. No repeat regions or remnants of insertion sequences were identified in this region.
The identification of two new glycosyltransferases in strain 33921 prompted us to examine a series of isolates to determine whether the lbgAB 33921 genes could be identified in additional isolates. Thirty-five isolates were subjected to dot blot hybridization using probes containing the lbgAB sequences from strain 35000HP or from 33921 (data not shown). Three of the 35 strains tested from a series of random isolates in the Totten collection reacted with the lbgAB 33921 probe, while the remainder reacted with the lbgAB 35000HP probe (data not shown). No isolate reacted with both probes. The strains that reacted with the lbgAB 33921 probe were HMC37, HMC65, and HMC112. To determine the sequence similarity of the strains that reacted with the lbgAB 33921 probe, we amplified the lbgAB region from HMC37, HMC65, and HMC112 using primers 5 (5Ј-AAAGA AATTACGGCAACA-3Ј) and 6 (5Ј-AGCTATGGAAAAAC CCTCTG-3Ј). Since White et al. (44) reported that strain HMC112 was a member of a second class of H. ducreyi organisms, we also amplified this region from other proposed class II strains CIP542 ATCC, DMC64, DMC111, and SSMC71 using the same primers. The sequence of each of these amplicons was 100% identical to the sequence determined for the lbgAB 33921 genes. These data suggest that strain 33921 and the two newly characterized isolates from the Totten collection are all class II organisms.
To determine the role that the lbgAB 33921 genes play in LOS biosynthesis, we made several attempts to insertionally inactivate the lbgAB 33921 genes in strain 33921 but were unable to genetically manipulate this strain. White et al. were also unable to genetically manipulate their class II isolates (44) . To overcome the inability to genetically modify strain 33921, we complemented defined glycosyltransferase mutants constructed in the strain 35000HP background. The lbgA 33921 gene and the lbgB 33921 genes were amplified by PCR, cloned into pCR2.1, and sequenced. These genes were then cloned into the shuttle vector pLS88. The resulting plasmids were designated pLBGA, pLBGB, pLBGBR, and pLBGAB (see Table 1 and Fig. 2 for  details) .
35000HP-RSM2 was the first strain that was complemented with the lbgAB 33921 genes. This strain contains a mutation in lbgB 35000HP (46) , the gene that encodes the DD-heptosyltrans- ferase; therefore, the most complex LOS glycoform produced by strain 35000HP-RSM2 is Glc␤1-4(Hep) 3 -Kdo-lipid A ( Fig.  1 ) (15, 42) . Since the structure of the LOS of strain 33921 is GlcNAc␤1-3Gal␤1-4Glc␤1-4(Hep) 3 Kdo-lipid A (Fig. 1) , the terminal glucose of the LOS glycoform of strain 35000HP-RSM2 should serve as a substrate for the addition of galactose when this strain is complemented with the strain 33921 galactosyltransferase. The plasmids pLBGA, pLBGB, and pLBGBR were electroporated into 35000HP-RSM2. Transformants were selected on chocolate agar plates containing streptomycin and designated 35000HP-RSM2(pLBGA), 35000HP-RSM2(pLBGB), and 35000HP-RSM2(pLBGBR), respectively. Purified LOS was extracted from the transformants and strains 35000HP and 35000HP-RSM2 and characterized by silver-stained SDS-PAGE (Fig. 3) . These analyses demonstrated that LOS from strain 35000HP-RSM2(pLBGA) contained a complex series of glycoforms (Fig. 3A, lane 5) . This series of glycoforms is similar to those produced by 35000HP LOS (Fig. 3A, lanes 1 and 6) . The slight differences seen in the LOS from these two strains are most likely due to the absence of the DD-Hep in the LOS from 35000HP-RSM2(pLBGA). Since 35000HP LOS is known to be extended by the addition of sialic acid, the LOS glycoforms present in the 35000HP-RSM2(pLBGA) were examined for evidence of sialylation. 35000HP-RSM2(pLBGA) LOS and 35000HP LOS were neuraminidase treated and examined by silver-stained SDS-PAGE. Figure 3B shows these LOS samples both with (lanes 2 and 4) and without (lanes 1 and 3) neuraminidase treatment. In both strains neuraminidase treatment alters the glycoforms visualized on the SDS-PAGE. Neuraminidase treatment alters the presence of one band in the 35000HP LOS (removal of the terminal NeuAc from the a-branch structure [see Fig. 1]) . Neuraminidase-treated 35000HP-RSM2(pLBGA) LOS has two bands missing instead of one as in the 35000HP LOS sample. These two bands in the 35000HP-RSM2(pLBGA) LOS likely correspond to the addition of sialic acid onto both the a-and b-branches of the 35000HP-RSM2(pLBGA) LOS. A sialylated b-branch was not detected in 35000HP LOS.
MS was used to further investigate the LOS structure of strain 35000HP-RSM2(pLBGA). Figure 4B shows a typical spectrum of 35000HP-RSM2(pLBGA) O-LOS. The major deprotonated molecular ions, [M-H] Ϫ , present at m/z 2,640 and 2,763 in this spectrum correspond to an LOS structure consisting of Hex 3 , HexNAc, Hep 3 , Kdo(P), and di-N-acyl lipid A (lipid AЈ) with one or two phosphoethanolamine (PEA) substitution(s), respectively. A predicted structure of the LOS for 35000HP-RSM2(pLBGA) is shown in Fig. 5 . The major 35000HP-RSM2(pLBGA) glycoform can be further extended by the addition of sialic acid (at m/z 2,931 and 3,054, with one or two PEA substitutions, respectively) and is referred to as the a-branch (Fig. 5) . Alternatively, the major glycoform can be further extended by the addition of a HexNAc (at m/z 2,843 and 2,966, with one or two PEA substitutions, respectively). This addition of the HexNAc is most likely the start of the b-branch LOS structure (Fig. 5) .
In contrast to the LOS from 35000HP-RSM2(pLBGA), both SDS-PAGE analyses (Fig. 3A, lanes 3 and 4) and MS analyses (data not shown) demonstrated that the LOS glycoforms produced by strains 35000HP-RSM2(pLBGB) and 35000HP-RSM2(pLBGBR) containing the lbgB 33921 gene, cloned in both orientations relative to the vector backbone, were identical in size to the glycoform produced by strain 35000HP-RSM2.
The MS data for strain 35000HP-RSM2(pLBGA) were consistent with the hypothesis that the lbgA 33921 gene encoded a galactosyltransferase with specificity for the nonreducing terminal glucose found in the LOS produced by 35000HP-RSM2. The more complex glycoforms seen in the 35000HP-RSM2(pLBGA) LOS were likely synthesized by 35000HP glycosyltransferases. This would mean that the 35000HP N-acetylglucosamine glycosyltransferase (LgtA) had a relaxed specificity, recognizing either Gal␤1-4Glc [for 35000HP-RSM2(pLBGA)] or Gal␤1-4DDHep␣1-6Glc (its normal substrate in 35000HP). To determine more conclusively whether lbgA 33921 encodes a galactosyltransferase, a strain with mutations in both lgtA and lbgB 35000HP was generated. This strain was designated 35000HP-RSM223. Since the glycosyltransferase, LgtA, was probably responsible for the addition of the HexNAc to the Gal␤1-4Glc in 35000HP-RSM2(pLBGA), we reasoned that if lbgA 33921 was expressed in the lgtA lbgB 35000HP double-mutant strain 35000HP-RSM223, the LOS glycoform would terminate in Gal␤1-4Glc. To test this hypothesis, strain 35000HP-RSM223 was transformed with pLBGA and designated 35000HP-RSM223(pLBGA).
LOS was extracted from strain 35000HP-RSM223(pLBGA) and compared to LOS isolated from 35000HP, 35000HP-FIG. 5. Predicted LOS structure for 35000HP-RSM2(pLBGA). Similar to the LOS from 35000HP, 35000HP-RSM2(pLBGA) seems to be able to generate both the a-branch and b-branch structures. "Hex*" indicates a hexose residue that was subsequently determined to be a galactose. Fig. 7A and B, respectively). The major deprotonated molecular ions, [M-H] Ϫ , in the spectrum from 35000HP-RSM223 O-LOS were at m/z 1,990, 2,113, and 2,236, corresponding to a structure containing Hex, Hep 3 , Kdo(P), lipid AЈ with zero, one, or two PEA substitution(s), respectively. The major molecular ions detected in the spectrum from 35000HP-RSM223(pLBGA) O-LOS were at m/z 2,152, 2,275, and 2,398, corresponding to a structure containing Hex 2 , Hep 3 , Kdo(P), lipid AЈ, with zero, one, or two PEA substitution(s), respectively. These data demonstrate that the difference between the major glycoforms expressed by 35000HP-RSM223 and the major glycoforms expressed by 35000HP-RSM223(pLBGA) is the addition of one hexose (ϩ162 Da). We predicted that this hexose is a galactose, based on the known LOS structure from 33921 (25) a single hexose moiety (data not shown). The predicted LOS structure for 35000HP-RSM223(pLBGA) is shown in Fig. 7 panel C and demonstrates that lbgA 33921 encodes a galactosyltransferase. Strain 35000HP-RSM223 was also transformed with a plasmid containing both lbgA 33921 and lbgB 33921 and was designated 35000HP-RSM223(pLBGAB). Both silverstained SDS-PAGE (Fig. 6, lane 5) and MS analyses (data not shown) demonstrated that the LOS from this strain was unchanged compared to the LOS from 35000HP-RSM2(pLBGA). Therefore, it is currently unclear what role, if any, lbgB 33921 plays in the biosynthesis of 33921 LOS.
In the present study, we demonstrated that 33921 had a genome gene arrangement similar to that of 35000HP, with the rpmE and xthA genes flanking two glycosyltransferases, lbgAB. However, the glycosyltransferases present in these two strains are not highly homologous. Unlike strain 35000HP, this region of DNA from strain 33921 does not contain a DD-heptosyltransferase. Both lbgA 35000HP and lbgA 33921 are galactosyltransferases (42); however, they recognize different acceptor sugars. LbgA 35000HP recognizes a terminal DD-heptose (42) , whereas the LbgA 33921 transferase recognizes a terminal glucose as its acceptor. Various H. ducreyi strains probed with the lbgAB genes from either 35000HP or 33921 demonstrated that strains reacted with one, but never both probes. These data demonstrate that the lbgAB genes can serve as good indicators of whether a strain is a class I or class II strain. Therefore, this information may be used as a tool for future characterization of H. ducreyi strains.
